-
More Patients Participating in Cancer ResearchA higher proportion of cancer patients are enrolling in research studies than previously thought, but many patients lack the access needed to participate.
by Kyle Bagenstose
-
Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung CancerThe drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
by Laura Gesualdi-Gilmore
-
Self-collection Broadens Access to HPV ScreeningFDA approval allows patients to collect samples for HPV test, lowering a barrier to an important cancer prevention tool.
by Taneia Surles
-
Facts and Stats
From Lab Experiment to Lifesaving TreatmentDecades of research and clinical trials led to CAR T-cell therapy becoming a critical blood cancer treatment.
by Thomas Celona
-
Extending Remissions in Lung CancerImmune checkpoint inhibitors are effective against non-small cell lung cancer in some patients. Researchers are investigating who benefits from the drugs and when they should be administered for maximum impact.
by Natalie Slivinski
-
TILs in Solid TumorsWith the FDA’s approval of the first tumor‑infiltrating lymphocyte (TIL) therapy to treat advanced melanoma, researchers seek to expand this type of cellular therapy to other solid tumors.
by Kendall K. Morgan
-
Forward Look
The Time FactorOncologist and researcher Arjun Gupta discusses time toxicity and why it is important.
by Ashley P. Taylor
-
Forward Look
Imaging Predicts Early Response to Melanoma ImmunotherapyResearch shows a scan can reveal treatment responses just one week after people with melanoma start immunotherapy.
by Anna Azvolinsky
-
Forward Look
A Different Chemotherapy Approach for Ovarian CancerStudy suggests heated chemotherapy delivered to the abdominal cavity extends survival in advanced ovarian cancer.
by Kris Conner
-
Forward Look
Some Breast Cancer Patients Can Skip RadiationResearch suggests postmenopausal women over 50 with low-risk hormone receptor-positive breast cancer may forgo radiation after surgery.
by Darcy Lewis
After a cancer diagnosis, people who are deaf or have hearing problems can struggle if accommodations don’t meet their communication needs.
by Eric Fitzsimmons
Is Immunotherapy Right for People Hospitalized With Advanced Cancer?Researchers find no evidence that immune checkpoint inhibitors benefit cancer patients getting inpatient care. They urge earlier consideration of palliative care.
by Kyle Bagenstose
Celebrity Cancer Stories Can Lack Important InformationNews coverage about public figures facing cancer frequently leaves out key details about the diagnosis and fails to provide background information on cancer.
by Laura Gesualdi Gilmore
AACR Annual Meeting 2025Immunotherapies, cancer vaccines and more from Cancer Today’s coverage of the AACR Annual Meeting 2025.
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
